BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 11399089)

  • 1. Enzymatic properties of recombinant Dnmt3a DNA methyltransferase from mouse: the enzyme modifies DNA in a non-processive manner and also methylates non-CpG [correction of non-CpA] sites.
    Gowher H; Jeltsch A
    J Mol Biol; 2001 Jun; 309(5):1201-8. PubMed ID: 11399089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The activity of the murine DNA methyltransferase Dnmt1 is controlled by interaction of the catalytic domain with the N-terminal part of the enzyme leading to an allosteric activation of the enzyme after binding to methylated DNA.
    Fatemi M; Hermann A; Pradhan S; Jeltsch A
    J Mol Biol; 2001 Jun; 309(5):1189-99. PubMed ID: 11399088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Murine DNA cytosine-C5 methyltransferase: pre-steady- and steady-state kinetic analysis with regulatory DNA sequences.
    Flynn J; Glickman JF; Reich NO
    Biochemistry; 1996 Jun; 35(23):7308-15. PubMed ID: 8652507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De novo CpG island methylation in human cancer cells.
    Jair KW; Bachman KE; Suzuki H; Ting AH; Rhee I; Yen RW; Baylin SB; Schuebel KE
    Cancer Res; 2006 Jan; 66(2):682-92. PubMed ID: 16423997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accuracy of DNA methylation pattern preservation by the Dnmt1 methyltransferase.
    Goyal R; Reinhardt R; Jeltsch A
    Nucleic Acids Res; 2006; 34(4):1182-8. PubMed ID: 16500889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dimethyl sulfoxide stimulates the catalytic activity of de novo DNA methyltransferase 3a (Dnmt3a) in vitro.
    Yokochi T; Robertson KD
    Bioorg Chem; 2004 Aug; 32(4):234-43. PubMed ID: 15210338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of 7,8-dihydro-8-oxoguanine on methylation of the CpG site by Dnmt3a.
    Maltseva DV; Baykov AA; Jeltsch A; Gromova ES
    Biochemistry; 2009 Feb; 48(6):1361-8. PubMed ID: 19161295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specificity of Dnmt1 for methylation of hemimethylated CpG sites resides in its catalytic domain.
    Bashtrykov P; Jankevicius G; Smarandache A; Jurkowska RZ; Ragozin S; Jeltsch A
    Chem Biol; 2012 May; 19(5):572-8. PubMed ID: 22633409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of methylation spreading in synthetic DNA sequences by the murine DNA methyltransferase.
    Tollefsbol TO; Hutchison CA
    J Mol Biol; 1997 Jun; 269(4):494-504. PubMed ID: 9217255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of chromatin structure on the enzymatic and DNA binding functions of DNA methyltransferases DNMT1 and Dnmt3a in vitro.
    Robertson AK; Geiman TM; Sankpal UT; Hager GL; Robertson KD
    Biochem Biophys Res Commun; 2004 Sep; 322(1):110-8. PubMed ID: 15313181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA (cytosine-5)-methyltransferases in mouse cells and tissues. Studies with a mechanism-based probe.
    Yoder JA; Soman NS; Verdine GL; Bestor TH
    J Mol Biol; 1997 Jul; 270(3):385-95. PubMed ID: 9237905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The de novo methylation activity of Dnmt3a is distinctly different than that of Dnmt1.
    Hsieh CL
    BMC Biochem; 2005 Mar; 6():6. PubMed ID: 15799776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preference of DNA methyltransferases for CpG islands in mouse embryonic stem cells.
    Hattori N; Abe T; Hattori N; Suzuki M; Matsuyama T; Yoshida S; Li E; Shiota K
    Genome Res; 2004 Sep; 14(9):1733-40. PubMed ID: 15310660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allosteric activator domain of maintenance human DNA (cytosine-5) methyltransferase and its role in methylation spreading.
    Pradhan S; Estève PO
    Biochemistry; 2003 May; 42(18):5321-32. PubMed ID: 12731873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA cytosine C5 methyltransferase Dnmt1: catalysis-dependent release of allosteric inhibition.
    Svedruzić ZM; Reich NO
    Biochemistry; 2005 Jul; 44(27):9472-85. PubMed ID: 15996102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Profound flanking sequence preference of Dnmt3a and Dnmt3b mammalian DNA methyltransferases shape the human epigenome.
    Handa V; Jeltsch A
    J Mol Biol; 2005 May; 348(5):1103-12. PubMed ID: 15854647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mouse Dnmt3a preferentially methylates linker DNA and is inhibited by histone H1.
    Takeshima H; Suetake I; Tajima S
    J Mol Biol; 2008 Nov; 383(4):810-21. PubMed ID: 18823905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells.
    Robert MF; Morin S; Beaulieu N; Gauthier F; Chute IC; Barsalou A; MacLeod AR
    Nat Genet; 2003 Jan; 33(1):61-5. PubMed ID: 12496760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous cytosine damage products alter the site selectivity of human DNA maintenance methyltransferase DNMT1.
    Valinluck V; Sowers LC
    Cancer Res; 2007 Feb; 67(3):946-50. PubMed ID: 17283125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Major and essential role for the DNA methylation mark in mouse embryogenesis and stable association of DNMT1 with newly replicated regions.
    Takebayashi S; Tamura T; Matsuoka C; Okano M
    Mol Cell Biol; 2007 Dec; 27(23):8243-58. PubMed ID: 17893328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.